These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15020232)

  • 21. Downregulation of secretory leukocyte proteinase inhibitor in chronic obstructive lung disease: the role of TGF-beta/Smads signaling pathways.
    Luo BL; Niu RC; Feng JT; Hu CP; Xie XY; Ma LJ
    Arch Med Res; 2008 May; 39(4):388-96. PubMed ID: 18375249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The secretory leukocyte protease inhibitor gene is a target of epidermal growth factor receptor action in endometrial epithelial cells.
    Velarde MC; Parisek SI; Eason RR; Simmen FA; Simmen RC
    J Endocrinol; 2005 Jan; 184(1):141-51. PubMed ID: 15642791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal induction of secretory leukocyte protease inhibitor (SLPI) in odontoblasts by lipopolysaccharide and wound infection.
    Choi BD; Jeong SJ; Wang G; Kim HJ; Kim BO; Hwang HK; Lim DS; Kim SH; Jeong MJ
    J Endod; 2009 Jul; 35(7):997-1002. PubMed ID: 19567322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel distribution of the secretory leucocyte proteinase inhibitor in kidney.
    Ohlsson S; Ljungkrantz I; Ohlsson K; Segelmark M; Wieslander J
    Mediators Inflamm; 2001 Dec; 10(6):347-50. PubMed ID: 11817677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of arsenicals on ultraviolet-radiation-induced growth arrest and related signaling events in human keratinocytes.
    Mudipalli A; Owen RD; Preston RJ
    Int J Oncol; 2005 Sep; 27(3):769-78. PubMed ID: 16077927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secretory leukocyte protease inhibitor in cancer development.
    Devoogdt N; Revets H; Ghassabeh GH; De Baetselier P
    Ann N Y Acad Sci; 2004 Dec; 1028():380-9. PubMed ID: 15650263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical localization of EGF, TGF-alpha, TGF-beta, and their receptors in rat corneas during healing of excimer laser ablation.
    Tuli SS; Liu R; Chen C; Blalock TD; Goldstein M; Schultz GS
    Curr Eye Res; 2006 Sep; 31(9):709-19. PubMed ID: 16966143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1.
    Påhlman LI; Jögi A; Gram M; Mori M; Egesten A
    BMC Pulm Med; 2015 Mar; 15():19. PubMed ID: 25851169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells.
    Devoogdt N; Hassanzadeh Ghassabeh G; Zhang J; Brys L; De Baetselier P; Revets H
    Proc Natl Acad Sci U S A; 2003 May; 100(10):5778-82. PubMed ID: 12732717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF.
    Hollborn M; Tenckhoff S; Jahn K; Iandiev I; Biedermann B; Schnurrbusch UE; Limb GA; Reichenbach A; Wolf S; Wiedemann P; Kohen L; Bringmann A
    Mol Vis; 2005 Jun; 11():397-413. PubMed ID: 15988409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic effects of acitretin and narrow-band UVB on inducing the expression of heparin-binding epidermal-growth-factor-like growth factor in normal human keratinocytes.
    Luo S; Peng Z; Zheng Y; Zhang L; Feng Y; Wang G
    Arch Dermatol Res; 2007 Oct; 299(8):409-13. PubMed ID: 17653734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The secretory leukocyte protease inhibitor is a type 1 insulin-like growth factor receptor-regulated protein that protects against liver metastasis by attenuating the host proinflammatory response.
    Wang N; Thuraisingam T; Fallavollita L; Ding A; Radzioch D; Brodt P
    Cancer Res; 2006 Mar; 66(6):3062-70. PubMed ID: 16540655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cloning and characterization of a murine secretory leukocyte protease inhibitor cDNA.
    Zitnik RJ; Zhang J; Kashem MA; Kohno T; Lyons DE; Wright CD; Rosen E; Goldberg I; Hayday AC
    Biochem Biophys Res Commun; 1997 Mar; 232(3):687-97. PubMed ID: 9126337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of menstrual status on antibacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture.
    Fahey JV; Wira CR
    J Infect Dis; 2002 Jun; 185(11):1606-13. PubMed ID: 12023766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-Azacytidine suppresses RNA polymerase II recruitment to the SLPI gene.
    Wada H; Kagoshima M; Ito K; Barnes PJ; Adcock IM
    Biochem Biophys Res Commun; 2005 May; 331(1):93-9. PubMed ID: 15845363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of secretory leukocyte protease inhibitor as an inhibitor of implantation serine proteinases.
    Sharma N; Kaur J; Xu H; Zur Nieden N; Rancourt D
    Mol Reprod Dev; 2008 Jul; 75(7):1136-42. PubMed ID: 18163438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression changes associated with altered growth and differentiation in benzo[a]pyrene or arsenic exposed normal human epidermal keratinocytes.
    Perez DS; Handa RJ; Yang RS; Campain JA
    J Appl Toxicol; 2008 May; 28(4):491-508. PubMed ID: 17879257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of SLPI (secretory leukocyte protease inhibitor) in human mast cells using immunohistochemistry and in situ hybridisation.
    Westin U; Polling A; Ljungkrantz I; Ohlsson K
    Biol Chem; 1999 Apr; 380(4):489-93. PubMed ID: 10355635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed cutaneous wound healing in mice lacking solute carrier 11a1 (formerly Nramp1): correlation with decreased expression of secretory leukocyte protease inhibitor.
    Thuraisingam T; Sam H; Moisan J; Zhang Y; Ding A; Radzioch D
    J Invest Dermatol; 2006 Apr; 126(4):890-901. PubMed ID: 16470178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of secretory leukocyte protease inhibitor (SLPI) in estradiol valerate (EV) induced polycystic ovary.
    Park JJ; Bae CS; Choi BD; Jeong SJ; Wang G; Lim DS; Kim BO; Cho YS; Kim SJ; Jeong MJ
    Arch Pharm Res; 2011 Aug; 34(8):1389-97. PubMed ID: 21910062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.